Legal Representation
Attorney
Jenevieve Maerker
USPTO Deadlines
Application History
9 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 6, 2021 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Apr 6, 2021 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Jan 12, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 21, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 21, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 21, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Sep 21, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 16, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 22, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005